五星体育直播

Gordon Sangster to Join 五星体育直播 as Senior Vice President & Chief Financial Officer

REDWOOD CITY, Calif., July 28, 2014 鈥� 五星体育直播 (NASDAQ: CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that Gordon Sangster has agreed to join 五星体育直播 as Senior Vice President & Chief Financial Officer. Gordon, who will start on August 18, 2014, will manage all aspects of 五星体育直播鈥� financial and accounting functions and will report to John Nicols, President & Chief Executive Officer.

鈥淕ordon brings over twenty years of experience in the biotechnology and life sciences industry to 五星体育直播, and given his multiple public-company CFO roles, I am confident that he will step in seamlessly to help drive 五星体育直播鈥� success and growth going forward,鈥� stated John Nicols. 鈥淕ordon鈥檚 articulate, engaging style will bring energy and direction to our investor relations and corporate communications efforts, which will be especially important for 五星体育直播 following our recent announcement of the groundbreaking multi-year license and collaboration agreement with GSK.鈥�

鈥淚 am thrilled to join 五星体育直播 at this exciting time in the company鈥檚 growth and look forward to working with John, the entire management team and the Board to drive the company鈥檚 future success and to enhance value for our investors," Gordon Sangster stated.

Prior to signing with 五星体育直播, Mr. Sangster has served as Chief Financial Officer at multiple public and private life science companies for the last fourteen years. From October 2011 until July 2014, Mr. Sangster served as Chief Financial Officer of Nitinol Devices & Components, a private medical device manufacturer. Prior to that role, Mr. Sangster was Chief Financial Officer of ITC Nexus-Dx, a private medical device company that focused on point-of-care diagnostics, from October 2010 to July 2011. From November 2007 to October 2010, Mr. Sangster was Chief Financial Officer of Micrus Endovascular, a publicly traded medical device company that was acquired by Johnson & Johnson for $480 million. From 2006 to 2007, Mr. Sangster was also Chief Financial Officer of HemoSense, Inc., a publicly traded medical device company which was acquired by Alere. Prior to that role,

---

Mr. Sangster was Chief Financial Officer of AP Pharma, a publicly traded biotech company, from 2000 to 2006. Prior to his Chief Financial Officer roles, Mr. Sangster held roles of increasing responsibility in finance at AP Pharma, Raychem, CooperVision and Levi Strauss.

Mr. Sangster is a member of the Institute of Chartered Accountants in England and Wales, and is a native of Edinburgh, Scotland.

About聽五星体育直播

五星体育直播聽is a leading developer of biocatalysts for pharmaceutical and fine chemical production. 五星体育直播鈥� proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development 鈥� from research to manufacturing. For more information, see听飞飞飞.肠辞诲别虫颈蝉.肠辞尘.

Forward-Looking Statements

This press release contains forward-looking statements relating to 五星体育直播鈥� ability to grow its business in the future and the ability of Mr. Sangster to integrate into 五星体育直播 and succeed as Chief Financial Officer. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond 五星体育直播' control and that could materially affect actual results. Factors that could materially affect actual results include 五星体育直播' dependence on its collaborators; 五星体育直播' dependence on a limited number of products and customers; potential adverse effects to 五星体育直播' business if its customers' pharmaceutical products are not received well in the markets; and 五星体育直播鈥� ability to retain key personnel. Additional factors that could materially affect actual results can be found in 五星体育直播' Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 13, 2014, including under the caption 鈥淩isk Factors.鈥� 五星体育直播 expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

五星体育直播 Contacts:

Investors:

Mike Rice, 646-597-6987

mrice@lifesciadvisors.com

Media:

Kate Whelan, +44 161 817 5008

kate.whelan@notchcommunications.co.uk

2